A randomized, double-blind, placebo-controlled, multiple dose study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of systemic AMG 108 [MEDI 8968] in subjects with osteoarthritis (OA).

Trial Profile

A randomized, double-blind, placebo-controlled, multiple dose study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of systemic AMG 108 [MEDI 8968] in subjects with osteoarthritis (OA).

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Jul 2011

At a glance

  • Drugs MEDI 8968 (Primary)
  • Indications Osteoarthritis
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 29 Jul 2011 Primary endpoint 'Western-Ontario-and-McMaster-Universities-Osteoarthritis-Index' has not been met.
    • 06 Nov 2007 Status changed from in progress to completed.
    • 31 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top